15Jun

[Comment] Dissecting premotor Parkinson’s disease with multimodality neuroimaging

Parkinson's disease is diagnosed when parkinsonism (ie, bradykinesia, rigidity, and resting tremor) is clinically apparent. Parkinsonism manifests when a dopaminergic deficit of about 80% is present in the striatum due to neuronal loss of about 60% in the substantia nigra pars compacta. Parkinson's disease has a premotor period of several years during which progressive neuronal loss occurs outside the substantia nigra in non-dopaminergic regions, leading to non-motor symptoms such as hyposmia, constipation, depression, and rapid eye movement (REM) sleep behaviour disorder.

Ander nieuws

20May

[Comment] A new step towards targeting tau

Progressive supranuclear palsy is a rare neurodegenerative disease characterised by an axial parkins...

naar nieuwsitem

20May

[Review] CSF and blood biomarkers for Parkinson’s disease

In the management of Parkinson's disease, reliable diagnostic and prognostic biomarkers are urg...

naar nieuwsitem

22Apr

Parkinson’s disease patient: ‘I can walk… it’s really helped me’

Parkinson's disease patient Gail Jardine can walk more freely after having a spinal implant fit...

naar nieuwsitem